Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Proteasome-dependent degradation of intracellular carbamylated proteins.

Desmons A, Okwieka A, Doué M, Gorisse L, Vuiblet V, Pietrement C, Gillery P, Jaisson S.

Aging (Albany NY). 2019 Jun 6. doi: 10.18632/aging.102002. [Epub ahead of print]

2.

New insights into spectral histopathology: infrared-based scoring of tumour aggressiveness of squamous cell lung carcinomas.

Gaydou V, Polette M, Gobinet C, Kileztky C, Angiboust JF, Birembaut P, Vuiblet V, Piot O.

Chem Sci. 2019 Mar 5;10(15):4246-4258. doi: 10.1039/c8sc04320e. eCollection 2019 Apr 21.

3.

Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.

Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A, Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL.

Kidney Int. 2019 Jun;95(6):1471-1485. doi: 10.1016/j.kint.2018.12.029. Epub 2019 Mar 5.

PMID:
30955869
4.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
5.

Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.

Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M.

Transplantation. 2018 Apr;102(4):688-698. doi: 10.1097/TP.0000000000002002.

PMID:
29135832
6.

[Skin pigmentation induced by meropenem and levofloxacin].

Garval E, Vuiblet V, Durlach A, Perceau G, Anuset D, Bernard P.

Ann Dermatol Venereol. 2017 Dec;144(12):793-798. doi: 10.1016/j.annder.2017.05.017. Epub 2017 Oct 12. French.

PMID:
29031417
7.

Label-free molecular imaging of the kidney.

Prentice BM, Caprioli RM, Vuiblet V.

Kidney Int. 2017 Sep;92(3):580-598. doi: 10.1016/j.kint.2017.03.052. Epub 2017 Jul 24. Review.

8.

Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency.

Lovric S, Goncalves S, Gee HY, Oskouian B, Srinivas H, Choi WI, Shril S, Ashraf S, Tan W, Rao J, Airik M, Schapiro D, Braun DA, Sadowski CE, Widmeier E, Jobst-Schwan T, Schmidt JM, Girik V, Capitani G, Suh JH, Lachaussée N, Arrondel C, Patat J, Gribouval O, Furlano M, Boyer O, Schmitt A, Vuiblet V, Hashmi S, Wilcken R, Bernier FP, Innes AM, Parboosingh JS, Lamont RE, Midgley JP, Wright N, Majewski J, Zenker M, Schaefer F, Kuss N, Greil J, Giese T, Schwarz K, Catheline V, Schanze D, Franke I, Sznajer Y, Truant AS, Adams B, Désir J, Biemann R, Pei Y, Ars E, Lloberas N, Madrid A, Dharnidharka VR, Connolly AM, Willing MC, Cooper MA, Lifton RP, Simons M, Riezman H, Antignac C, Saba JD, Hildebrandt F.

J Clin Invest. 2017 Mar 1;127(3):912-928. doi: 10.1172/JCI89626. Epub 2017 Feb 6.

9.

Renal involvement in lysinuric protein intolerance: contribution of pathology to assessment of heterogeneity of renal lesions.

Estève E, Krug P, Hummel A, Arnoux JB, Boyer O, Brassier A, de Lonlay P, Vuiblet V, Gobin S, Salomon R, Piètrement C, Bonnefont JP, Servais A, Galmiche L.

Hum Pathol. 2017 Apr;62:160-169. doi: 10.1016/j.humpath.2016.12.021. Epub 2017 Jan 11.

PMID:
28087478
10.

Imbalance of the Vanin-1 Pathway in Systemic Sclerosis.

Kavian N, Mehlal S, Marut W, Servettaz A, Giessner C, Bourges C, Nicco C, Chéreau C, Lemaréchal H, Dutilh MF, Cerles O, Guilpain P, Vuiblet V, Chouzenoux S, Galland F, Quere I, Weill B, Naquet P, Batteux F.

J Immunol. 2016 Oct 15;197(8):3326-3335. Epub 2016 Sep 19.

11.

Raman-based detection of hydroxyethyl starch in kidney allograft biopsies as a potential marker of allograft quality in kidney transplant recipients.

Vuiblet V, Fere M, Bankole E, Wynckel A, Gobinet C, Birembaut P, Piot O, Rieu P.

Sci Rep. 2016 Sep 9;6:33045. doi: 10.1038/srep33045.

12.

Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis.

Jarrot PA, Chiche L, Hervier B, Daniel L, Vuiblet V, Bardin N, Bertin D, Terrier B, Amoura Z, Andrés E, Rondeau E, Hamidou M, Pennaforte JL, Halfon P, Daugas E, Dussol B, Puéchal X, Kaplanski G, Jourde-Chiche N.

Medicine (Baltimore). 2016 May;95(22):e3748. doi: 10.1097/MD.0000000000003748.

13.

Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.

Belmokhtar K, Robert T, Ortillon J, Braconnier A, Vuiblet V, Boulagnon-Rombi C, Diebold MD, Pietrement C, Schmidt AM, Rieu P, Touré F.

Arterioscler Thromb Vasc Biol. 2016 May;36(5):800-9. doi: 10.1161/ATVBAHA.115.306349. Epub 2016 Mar 17.

PMID:
26988587
14.

Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.

Thierry A, Le Meur Y, Ecotière L, Abou-Ayache R, Etienne I, Laurent C, Vuiblet V, Colosio C, Bouvier N, Aldigier JC, Rerolle JP, Javaugue V, Gand E, Bridoux F, Essig M, Hurault de Ligny B, Touchard G.

Transpl Int. 2016 Jan;29(1):23-33. doi: 10.1111/tri.12627. Erratum in: Transpl Int. 2016 Jul;29(7):833. Lemeur, Yann [corrected to Le Meur, Yannick].

15.

Protein carbamylation is a hallmark of aging.

Gorisse L, Pietrement C, Vuiblet V, Schmelzer CE, Köhler M, Duca L, Debelle L, Fornès P, Jaisson S, Gillery P.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1191-6. doi: 10.1073/pnas.1517096113. Epub 2015 Dec 28.

16.

Renal Graft Fibrosis and Inflammation Quantification by an Automated Fourier-Transform Infrared Imaging Technique.

Vuiblet V, Fere M, Gobinet C, Birembaut P, Piot O, Rieu P.

J Am Soc Nephrol. 2016 Aug;27(8):2382-91. doi: 10.1681/ASN.2015050601. Epub 2015 Dec 18.

17.

Renal Involvement in a French Paediatric Cohort of Patients with Lysinuric Protein Intolerance.

Nicolas C, Bednarek N, Vuiblet V, Boyer O, Brassier A, De Lonlay P, Galmiche L, Krug P, Baudouin V, Pichard S, Schiff M, Pietrement C.

JIMD Rep. 2016;29:11-17. Epub 2015 Nov 26.

18.

Contribution of Raman spectroscopy in nephrology: a candidate technique to detect hydroxyethyl starch of third generation in osmotic renal lesions.

Vuiblet V, Nguyen TT, Wynckel A, Fere M, Van-Gulick L, Untereiner V, Birembaut P, Rieu P, Piot O.

Analyst. 2015 Nov 7;140(21):7382-90. doi: 10.1039/c5an00821b.

PMID:
26413856
19.

Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.

Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.

Kidney Int. 2015 Oct;88(4):815-22. doi: 10.1038/ki.2015.158. Epub 2015 Jun 10.

PMID:
26061544
20.

Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsA.

Rostaing L, Hertig A, Albano L, Anglicheau D, Durrbach A, Vuiblet V, Moulin B, Merville P, Hazzan M, Lang P, Touchard G, Hurault deLigny B, Quéré S, Di Giambattista F, Dubois YC, Rondeau E; CERTITEM Study Group.

Am J Transplant. 2015 May;15(5):1303-12. doi: 10.1111/ajt.13132. Epub 2015 Mar 23.

21.

Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.

Goury A, Meghraoui-Kheddar A, Belmokhtar K, Vuiblet V, Ortillon J, Jaisson S, Devy J, Le Naour R, Tabary T, Cohen JH, Schmidt AM, Rieu P, Touré F.

J Immunol. 2015 Apr 15;194(8):3612-22. doi: 10.4049/jimmunol.1402342. Epub 2015 Mar 11.

22.

Crystalline light chain proximal tubulopathy with chronic renal failure and silicone gel breast implants: 1 case report.

Figueres ML, Beaume J, Vuiblet V, Rabant M, Bassilios N, Herody M, Touchard G, Noël LH.

Hum Pathol. 2015 Jan;46(1):165-8. doi: 10.1016/j.humpath.2014.10.008. Epub 2014 Oct 24.

PMID:
25454480
23.

C3 nephritic factor associated with C3 glomerulopathy in children.

Nicolas C, Vuiblet V, Baudouin V, Macher MA, Vrillon I, Biebuyck-Gouge N, Dehennault M, Gié S, Morin D, Nivet H, Nobili F, Ulinski T, Ranchin B, Marinozzi MC, Ngo S, Frémeaux-Bacchi V, Pietrement C.

Pediatr Nephrol. 2014 Jan;29(1):85-94. doi: 10.1007/s00467-013-2605-6. Epub 2013 Sep 26.

PMID:
24068526
24.

Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation.

Porignaux R, Vuiblet V, Barbe C, Nguyen Y, Lavaud S, Toupance O, Andréoletti L, Rieu P, Lévêque N.

J Med Virol. 2013 Jun;85(6):1115-21. doi: 10.1002/jmv.23557.

PMID:
23588740
25.

Microbiological diagnosis of severe diarrhea in kidney transplant recipients by use of multiplex PCR assays.

Coste JF, Vuiblet V, Moustapha B, Bouin A, Lavaud S, Toupance O, de Rougemont A, Benejat L, Megraud F, Wolak-Thierry A, Villena I, Chemla C, Le Magrex E, de Champs C, Andreoletti L, Rieu P, Leveque N.

J Clin Microbiol. 2013 Jun;51(6):1841-9. doi: 10.1128/JCM.03366-12. Epub 2013 Apr 3.

26.

Long-term impact of subclinical inflammation diagnosed by protocol biopsy one year after renal transplantation.

Thierry A, Thervet E, Vuiblet V, Goujon JM, Machet MC, Noel LH, Rioux-Leclercq N, Comoz F, Cordonnier C, François A, Marcellin L, Girardot-Seguin S, Touchard G.

Am J Transplant. 2011 Oct;11(10):2153-61. doi: 10.1111/j.1600-6143.2011.03695.x. Epub 2011 Aug 22.

27.

Sirolimus-based regimen is associated with decreased expression of glomerular vascular endothelial growth factor.

Vuiblet V, Birembaut P, François A, Cordonnier C, Noel LH, Goujon JM, Paraf F, Machet MC, Girardot-Seguin S, Lebranchu Y, Rieu P.

Nephrol Dial Transplant. 2012 Jan;27(1):411-6. doi: 10.1093/ndt/gfr261. Epub 2011 May 26.

PMID:
21617191
28.

[Schoenlein-Henoch purpura as a presentation of squamous cell bronchial carcinoma].

Angelier AS, Petit L, Wynckel A, Vuiblet V, Birembaut P, Toubas O, Lebargy F, Deslee G.

Rev Mal Respir. 2011 Mar;28(3):372-6. doi: 10.1016/j.rmr.2010.09.033. Epub 2011 Feb 23. French.

PMID:
21482344
29.

[Membranous glomerulonephritis as a paraneoplastic manifestation of melanoma].

Sultan-Bichat N, Vuiblet V, Winckel A, Journet J, Goedel AL, Khoury A, Bernard P, Grange F.

Ann Dermatol Venereol. 2011 Jan;138(1):46-9. doi: 10.1016/j.annder.2010.10.024. Epub 2010 Nov 30. French.

PMID:
21276462
30.

[Bariatric surgery, calcium oxalate urinary stones and oxalate nephropathy].

Montagnac R, Schendel A, Vuiblet V, Peilleron B, Piot O.

Nephrol Ther. 2011 Feb;7(1):38-45. doi: 10.1016/j.nephro.2010.10.009. Epub 2010 Dec 3. French.

PMID:
21130057
31.

Renal involvement in Castleman disease.

El Karoui K, Vuiblet V, Dion D, Izzedine H, Guitard J, Frimat L, Delahousse M, Remy P, Boffa JJ, Pillebout E, Galicier L, Noël LH, Daugas E.

Nephrol Dial Transplant. 2011 Feb;26(2):599-609. doi: 10.1093/ndt/gfq427. Epub 2010 Jul 23.

PMID:
20656751
32.

Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model.

Kavian N, Servettaz A, Mongaret C, Wang A, Nicco C, Chéreau C, Grange P, Vuiblet V, Birembaut P, Diebold MD, Weill B, Dupin N, Batteux F.

Arthritis Rheum. 2010 Nov;62(11):3477-87. doi: 10.1002/art.27626. Erratum in: Arthritis Rheum. 2013 May;65(5):1231.

33.

[Renal diseases in cystic fibrosis].

Montagnac R, Sanlaville F, Soto B, Vuiblet V, Schillinger F.

Nephrol Ther. 2009 Nov;5(6):550-8. doi: 10.1016/j.nephro.2009.05.005. Epub 2009 Jul 8. French.

PMID:
19589743
34.

Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.

Servettaz A, Goulvestre C, Kavian N, Nicco C, Guilpain P, Chéreau C, Vuiblet V, Guillevin L, Mouthon L, Weill B, Batteux F.

J Immunol. 2009 May 1;182(9):5855-64. doi: 10.4049/jimmunol.0803705.

Supplemental Content

Loading ...
Support Center